IL2 and AIDS: For example, for their anti-tumor activity, IFN-α and IL-2 have been approved by the Food and Drug Administration (FDA) for the treatment of various cancers (melanoma, follicular lymphoma, hairy cell leukemia, acquired immunodeficiency syndrome (AIDS)-associated Kaposi’s sarcoma, and renal cell carcinoma) [67,68].